Wenzhou Kangning Hospital Co. Ltd
Wenzhou Kangning Hospital Co., Ltd., together with its subsidiaries, operates a network of healthcare facilities in the People's Republic of China. The company provides psychiatric specialty care and elderly rehabilitation services. It is also involved in property leasing and management; provision of hospital management, medical services, technology, and nursing care services; drug retail and pha… Read more
Wenzhou Kangning Hospital Co. Ltd (4WK) - Net Assets
Latest net assets as of June 2025: €1.36 Billion EUR
Based on the latest financial reports, Wenzhou Kangning Hospital Co. Ltd (4WK) has net assets worth €1.36 Billion EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.05 Billion) and total liabilities (€1.69 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.36 Billion |
| % of Total Assets | 44.65% |
| Annual Growth Rate | 3.23% |
| 5-Year Change | 2.2% |
| 10-Year Change | N/A |
| Growth Volatility | 4.43 |
Wenzhou Kangning Hospital Co. Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Wenzhou Kangning Hospital Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wenzhou Kangning Hospital Co. Ltd (2016–2024)
The table below shows the annual net assets of Wenzhou Kangning Hospital Co. Ltd from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.34 Billion | -4.61% |
| 2023-12-31 | €1.41 Billion | +6.21% |
| 2022-12-31 | €1.33 Billion | +4.31% |
| 2021-12-31 | €1.27 Billion | -3.30% |
| 2020-12-31 | €1.31 Billion | +4.19% |
| 2019-12-31 | €1.26 Billion | +4.67% |
| 2018-12-31 | €1.21 Billion | +8.53% |
| 2017-12-31 | €1.11 Billion | +6.64% |
| 2016-12-31 | €1.04 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wenzhou Kangning Hospital Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 146.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €344.29 Million | 28.15% |
| Other Components | €878.73 Million | 71.85% |
| Total Equity | €1.22 Billion | 100.00% |
Wenzhou Kangning Hospital Co. Ltd Competitors by Market Cap
The table below lists competitors of Wenzhou Kangning Hospital Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TGLT S.A
PINK:TGLTY
|
$9.60 Million |
|
SMS Lifesciences India Limited
NSE:SMSLIFE
|
$9.61 Million |
|
Swiftmerge Acquisition Corp
NASDAQ:IVCP
|
$9.61 Million |
|
PT Surya Esa Perkasa Tbk
STU:71S
|
$9.61 Million |
|
ELTON S.A. NAM. EO 052
F:Y1O
|
$9.60 Million |
|
Lotte Chemical Titan Tbk PT
JK:FPNI
|
$9.60 Million |
|
Condor Resources Inc
PINK:CNRIF
|
$9.60 Million |
|
Barrel Co. Ltd
KQ:267790
|
$9.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wenzhou Kangning Hospital Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,265,064,696 to 1,223,012,795, a change of -42,051,902 (-3.3%).
- Net income of 65,610,189 contributed positively to equity growth.
- Dividend payments of 71,731,090 reduced retained earnings.
- Other factors decreased equity by 35,931,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €65.61 Million | +5.36% |
| Dividends Paid | €71.73 Million | -5.87% |
| Other Changes | €-35.93 Million | -2.94% |
| Total Change | €- | -3.32% |
Book Value vs Market Value Analysis
This analysis compares Wenzhou Kangning Hospital Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.05x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €14.40 | €0.91 | x |
| 2018-12-31 | €14.85 | €0.91 | x |
| 2019-12-31 | €15.42 | €0.91 | x |
| 2020-12-31 | €16.24 | €0.91 | x |
| 2021-12-31 | €16.07 | €0.91 | x |
| 2022-12-31 | €16.11 | €0.91 | x |
| 2023-12-31 | €16.96 | €0.91 | x |
| 2024-12-31 | €16.83 | €0.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wenzhou Kangning Hospital Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.36%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.97%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 2.46x
- Recent ROE (5.36%) is above the historical average (4.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 6.83% | 16.57% | 0.26x | 1.59x | €-32.01 Million |
| 2017 | 4.67% | 7.36% | 0.39x | 1.61x | €-56.11 Million |
| 2018 | 7.19% | 10.80% | 0.41x | 1.64x | €-31.50 Million |
| 2019 | 4.92% | 6.66% | 0.41x | 1.82x | €-59.16 Million |
| 2020 | 5.78% | 6.79% | 0.46x | 1.86x | €-51.18 Million |
| 2021 | 3.67% | 3.40% | 0.55x | 1.98x | €-75.86 Million |
| 2022 | -2.02% | -1.63% | 0.56x | 2.20x | €-144.38 Million |
| 2023 | 6.79% | 5.38% | 0.52x | 2.41x | €-40.56 Million |
| 2024 | 5.36% | 3.97% | 0.55x | 2.46x | €-56.69 Million |
Industry Comparison
This section compares Wenzhou Kangning Hospital Co. Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,598,212,054
- Average return on equity (ROE) among peers: 7.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wenzhou Kangning Hospital Co. Ltd (4WK) | €1.36 Billion | 6.83% | 1.24x | $9.60 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |